| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.867 | 0 | 0.922 | Anabolic | 0.661 0.001 DB00624 0.575 0.001 DBMET00558 0.206 0.004 DBMET00593 0.236 0.002 DBMET00571 0.922 0 DBMET00574 0.392 0.001 DBMET02832 0.392 0.001 DBMET02833 0.392 0.001 DBMET02834 | DBMET00574 | |
| 0.825 | 0.004 | 0.926 | Cholesterol antagonist | 0.818 0.004 DB00624 0.788 0.004 DBMET00558 0.926 0.002 DBMET00593 0.918 0.002 DBMET00571 0.892 0.003 DBMET00574 0.821 0.004 DBMET02832 0.821 0.004 DBMET02833 0.821 0.004 DBMET02834 | DBMET00593 | |
| 0.792 | 0.002 | 0.824 | Aromatase inhibitor | 0.824 0.002 DB00624 0.715 0.002 DBMET00558 0.075 0.03 DBMET00593 0.097 0.022 DBMET00571 0.662 0.002 DBMET00574 0.602 0.003 DBMET02832 0.602 0.003 DBMET02833 0.602 0.003 DBMET02834 | DB00624 | |
| 0.793 | 0.013 | 0.911 | Transcription factor NF kappa B inhibitor | 0.8 0.013 DB00624 0.788 0.014 DBMET00558 0.909 0.005 DBMET00593 0.911 0.005 DBMET00571 0.653 0.026 DBMET00574 0.725 0.018 DBMET02832 0.725 0.018 DBMET02833 0.725 0.018 DBMET02834 | DBMET00571 | |
| 0.781 | 0.018 | 0.888 | Antiinflammatory | 0.841 0.01 DB00624 0.806 0.014 DBMET00558 0.888 0.005 DBMET00593 0.87 0.007 DBMET00571 0.797 0.016 DBMET00574 0.829 0.012 DBMET02832 0.829 0.012 DBMET02833 0.829 0.012 DBMET02834 | DBMET00593 | |
| 0.736 | 0.001 | 0.844 | Androgen agonist | 0.844 0.001 DB00624 0.799 0.001 DBMET00558 0.203 0.005 DBMET00593 0.315 0.003 DBMET00571 0.69 0.001 DBMET00574 0.64 0.001 DBMET02832 0.64 0.001 DBMET02833 0.64 0.001 DBMET02834 | DB00624 | |
| 0.708 | 0.029 | 0.847 | Apoptosis agonist | 0.774 0.02 DB00624 0.799 0.017 DBMET00558 0.838 0.012 DBMET00593 0.814 0.015 DBMET00571 0.677 0.034 DBMET00574 0.847 0.011 DBMET02832 0.847 0.011 DBMET02833 0.847 0.011 DBMET02834 | DBMET02834 | |
| 0.672 | 0.004 | 0.827 | Anesthetic general | 0.788 0.003 DB00624 0.827 0.002 DBMET00558 0.799 0.002 DBMET00593 0.809 0.002 DBMET00571 0.367 0.021 DBMET00574 0.808 0.002 DBMET02832 0.808 0.002 DBMET02833 0.808 0.002 DBMET02834 | DBMET00558 | |
| 0.676 | 0.027 | 0.836 | Caspase 9 stimulant | 0.776 0.014 DB00624 0.771 0.015 DBMET00558 0.836 0.007 DBMET00593 0.814 0.009 DBMET00571 0.282 0.215 DBMET00574 0.807 0.01 DBMET02832 0.807 0.01 DBMET02833 0.807 0.01 DBMET02834 | DBMET00593 | |
| 0.63 | 0.003 | 0.834 | Androgen antagonist | 0.834 0.002 DB00624 0.788 0.002 DBMET00558 0.151 0.022 DBMET00593 0.243 0.01 DBMET00571 0.346 0.006 DBMET00574 0.634 0.003 DBMET02832 0.634 0.003 DBMET02833 0.634 0.003 DBMET02834 | DB00624 | |
| 0.576 | 0.016 | 0.621 | Immunosuppressant | 0.575 0.016 DB00624 0.547 0.021 DBMET00558 0.591 0.014 DBMET00593 0.621 0.011 DBMET00571 0.5 0.033 DBMET00574 0.559 0.019 DBMET02832 0.559 0.019 DBMET02833 0.559 0.019 DBMET02834 | DBMET00571 | |
| 0.559 | 0.001 | 0.61 | Aldosterone antagonist | 0.61 0.001 DB00624 0.3 0.003 DBMET00558 0.073 0.013 DBMET00574 0.29 0.003 DBMET02832 0.29 0.003 DBMET02833 0.29 0.003 DBMET02834 | DB00624 | |
| 0.55 | 0.002 | 0.726 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.726 0.002 DB00624 0.625 0.002 DBMET00558 0.031 0.009 DBMET00571 0.103 0.004 DBMET00574 0.594 0.002 DBMET02832 0.594 0.002 DBMET02833 0.594 0.002 DBMET02834 | DB00624 | |
| 0.547 | 0.005 | 0.753 | Diuretic | 0.688 0.004 DB00624 0.6 0.005 DBMET00558 0.696 0.004 DBMET00593 0.712 0.004 DBMET00571 0.753 0.003 DBMET00574 0.506 0.007 DBMET02832 0.506 0.007 DBMET02833 0.506 0.007 DBMET02834 | DBMET00574 | |
| 0.525 | 0.003 | 0.615 | Lipocortins synthesis antagonist | 0.615 0.002 DB00624 0.589 0.002 DBMET00558 0.488 0.004 DBMET00593 0.455 0.005 DBMET00571 0.478 0.004 DBMET00574 0.612 0.002 DBMET02832 0.612 0.002 DBMET02833 0.612 0.002 DBMET02834 | DB00624 | |
| 0.521 | 0.005 | 0.567 | Interferon gamma antagonist | 0.541 0.004 DB00624 0.49 0.006 DBMET00558 0.539 0.004 DBMET00593 0.567 0.003 DBMET00571 0.219 0.035 DBMET00574 0.458 0.008 DBMET02832 0.458 0.008 DBMET02833 0.458 0.008 DBMET02834 | DBMET00571 | |
| 0.515 | 0.013 | 0.725 | Hypoxia-inducible factor 1 alpha inhibitor | 0.725 0.004 DB00624 0.607 0.007 DBMET00558 0.624 0.006 DBMET00593 0.673 0.005 DBMET00571 0.302 0.064 DBMET00574 0.595 0.008 DBMET02832 0.595 0.008 DBMET02833 0.595 0.008 DBMET02834 | DB00624 | |
| 0.489 | 0.002 | 0.501 | Cholesterol synthesis inhibitor | 0.416 0.004 DB00624 0.423 0.004 DBMET00558 0.363 0.006 DBMET00593 0.367 0.006 DBMET00571 0.501 0.002 DBMET00574 0.456 0.003 DBMET02832 0.456 0.003 DBMET02833 0.456 0.003 DBMET02834 | DBMET00574 | |
| 0.488 | 0.004 | 0.736 | Estrogen agonist | 0.683 0.003 DB00624 0.701 0.003 DBMET00558 0.463 0.004 DBMET00593 0.491 0.004 DBMET00571 0.677 0.003 DBMET00574 0.736 0.002 DBMET02832 0.736 0.002 DBMET02833 0.736 0.002 DBMET02834 | DBMET02834 | |
| 0.502 | 0.02 | 0.664 | Apoptosis antagonist | 0.573 0.012 DB00624 0.576 0.012 DBMET00558 0.664 0.005 DBMET00593 0.655 0.005 DBMET00571 0.45 0.028 DBMET00574 0.647 0.005 DBMET02832 0.647 0.005 DBMET02833 0.647 0.005 DBMET02834 | DBMET00593 | |
| 0.485 | 0.009 | 0.503 | P-glycoprotein inhibitor | 0.482 0.009 DB00624 0.486 0.009 DBMET00558 0.34 0.022 DBMET00593 0.328 0.024 DBMET00571 0.148 0.12 DBMET00574 0.503 0.008 DBMET02832 0.503 0.008 DBMET02833 0.503 0.008 DBMET02834 | DBMET02834 | |
| 0.473 | 0.001 | 0.473 | 5-Alpha-reductase inhibitor | 0.431 0.002 DB00624 0.417 0.002 DBMET00558 0.252 0.004 DBMET00593 0.321 0.003 DBMET00571 0.216 0.004 DBMET00574 0.354 0.002 DBMET02832 0.354 0.002 DBMET02833 0.354 0.002 DBMET02834 | ||
| 0.485 | 0.015 | 0.502 | DNA damaging | 0.502 0.014 DB00624 0.49 0.015 DBMET00558 0.48 0.016 DBMET00593 0.488 0.015 DBMET00571 0.204 0.112 DBMET00574 0.461 0.018 DBMET02832 0.461 0.018 DBMET02833 0.461 0.018 DBMET02834 | DB00624 | |
| 0.475 | 0.005 | 0.692 | NOS3 expression enhancer | 0.692 0.003 DB00624 0.489 0.005 DBMET00558 0.528 0.005 DBMET00593 0.426 0.007 DBMET00571 0.25 0.027 DBMET00574 0.589 0.004 DBMET02832 0.589 0.004 DBMET02833 0.589 0.004 DBMET02834 | DB00624 | |
| 0.465 | 0.006 | 0.627 | Sodium/bile acid cotransporter inhibitor | 0.509 0.004 DB00624 0.566 0.002 DBMET00558 0.514 0.003 DBMET00593 0.475 0.005 DBMET00571 0.515 0.003 DBMET00574 0.627 0.001 DBMET02832 0.627 0.001 DBMET02833 0.627 0.001 DBMET02834 | DBMET02834 | |
| 0.448 | 0.02 | 0.715 | Nitric oxide antagonist | 0.539 0.013 DB00624 0.645 0.008 DBMET00558 0.715 0.005 DBMET00593 0.657 0.007 DBMET00571 0.41 0.024 DBMET00574 0.69 0.006 DBMET02832 0.69 0.006 DBMET02833 0.69 0.006 DBMET02834 | DBMET00593 | |
| 0.422 | 0.001 | 0.462 | 5-Alpha-reductase 1 inhibitor | 0.462 0.001 DB00624 0.404 0.002 DBMET00558 0.023 0.01 DBMET00593 0.058 0.007 DBMET00571 0.105 0.004 DBMET00574 0.257 0.002 DBMET02832 0.257 0.002 DBMET02833 0.257 0.002 DBMET02834 | DB00624 | |
| 0.437 | 0.018 | 0.517 | Interleukin 2 agonist | 0.517 0.006 DB00624 0.445 0.017 DBMET00558 0.496 0.009 DBMET00593 0.502 0.008 DBMET00571 0.317 0.062 DBMET00574 0.472 0.012 DBMET02832 0.472 0.012 DBMET02833 0.472 0.012 DBMET02834 | DB00624 | |
| 0.427 | 0.009 | 0.524 | Platelet adhesion inhibitor | 0.309 0.031 DB00624 0.33 0.025 DBMET00558 0.524 0.005 DBMET00593 0.457 0.007 DBMET00571 0.411 0.01 DBMET00574 0.404 0.011 DBMET02832 0.404 0.011 DBMET02833 0.404 0.011 DBMET02834 | DBMET00593 | |
| 0.415 | 0.001 | 0.605 | RNA-directed RNA polymerase stimulant | 0.55 0.001 DB00624 0.605 0.001 DBMET00558 0.354 0.002 DBMET00593 0.497 0.001 DBMET00571 0.471 0.001 DBMET00574 0.587 0.001 DBMET02832 0.587 0.001 DBMET02833 0.587 0.001 DBMET02834 | DBMET00558 | |
| 0.408 | 0.006 | 0.408 | Antipruritic | 0.352 0.009 DB00624 0.239 0.028 DBMET00558 0.135 0.115 DBMET00571 0.16 0.083 DBMET00574 0.217 0.039 DBMET02832 0.217 0.039 DBMET02833 0.217 0.039 DBMET02834 | ||
| 0.398 | 0.001 | 0.438 | 5-Alpha-reductase 2 inhibitor | 0.438 0.001 DB00624 0.425 0.001 DBMET00558 0.135 0.004 DBMET00593 0.185 0.003 DBMET00571 0.118 0.004 DBMET00574 0.312 0.002 DBMET02832 0.312 0.002 DBMET02833 0.312 0.002 DBMET02834 | DB00624 | |
| 0.41 | 0.021 | 0.41 | Psychostimulant | 0.319 0.038 DB00624 0.235 0.064 DBMET00558 0.165 0.104 DBMET00593 0.255 0.057 DBMET00571 0.19 0.086 DBMET02832 0.19 0.086 DBMET02833 0.19 0.086 DBMET02834 | ||
| 0.377 | 0.002 | 0.47 | Bile acid receptor antagonist | 0.35 0.003 DB00624 0.345 0.003 DBMET00558 0.233 0.004 DBMET00593 0.147 0.008 DBMET00571 0.291 0.003 DBMET00574 0.47 0.002 DBMET02832 0.47 0.002 DBMET02833 0.47 0.002 DBMET02834 | DBMET02834 | |
| 0.393 | 0.028 | 0.567 | Tumour necrosis factor alpha release inhibitor | 0.367 0.034 DB00624 0.459 0.018 DBMET00558 0.567 0.009 DBMET00593 0.53 0.012 DBMET00571 0.418 0.024 DBMET00574 0.371 0.033 DBMET02832 0.371 0.033 DBMET02833 0.371 0.033 DBMET02834 | DBMET00593 | |
| 0.432 | 0.075 | 0.811 | Cyclophilin D inhibitor | 0.39 0.096 DB00624 0.438 0.072 DBMET00558 0.811 0.006 DBMET00593 0.746 0.01 DBMET00571 0.295 0.167 DBMET00574 0.57 0.033 DBMET02832 0.57 0.033 DBMET02833 0.57 0.033 DBMET02834 | DBMET00593 | |
| 0.356 | 0.003 | 0.584 | Estradiol 17 beta-dehydrogenase inhibitor | 0.584 0.002 DB00624 0.533 0.002 DBMET00558 0.04 0.031 DBMET00571 0.122 0.008 DBMET00574 0.443 0.002 DBMET02832 0.443 0.002 DBMET02833 0.443 0.002 DBMET02834 | DB00624 | |
| 0.352 | 0.005 | 0.663 | Estrogen antagonist | 0.662 0.003 DB00624 0.654 0.003 DBMET00558 0.256 0.008 DBMET00593 0.276 0.007 DBMET00571 0.251 0.008 DBMET00574 0.663 0.003 DBMET02832 0.663 0.003 DBMET02833 0.663 0.003 DBMET02834 | DBMET02834 | |
| 0.397 | 0.05 | 0.658 | Immunostimulant | 0.429 0.042 DB00624 0.436 0.04 DBMET00558 0.658 0.011 DBMET00593 0.626 0.014 DBMET00571 0.511 0.028 DBMET00574 0.459 0.035 DBMET02832 0.459 0.035 DBMET02833 0.459 0.035 DBMET02834 | DBMET00593 | |
| 0.338 | 0.004 | 0.713 | Estrogen receptor alpha antagonist | 0.713 0.002 DB00624 0.475 0.004 DBMET00558 0.091 0.034 DBMET00574 0.411 0.004 DBMET02832 0.411 0.004 DBMET02833 0.411 0.004 DBMET02834 | DB00624 | |
| 0.351 | 0.019 | 0.694 | Hepatoprotectant | 0.396 0.014 DB00624 0.516 0.006 DBMET00558 0.689 0.004 DBMET00593 0.694 0.004 DBMET00571 0.466 0.009 DBMET00574 0.581 0.005 DBMET02832 0.581 0.005 DBMET02833 0.581 0.005 DBMET02834 | DBMET00571 | |
| 0.362 | 0.033 | 0.52 | Hypolipemic | 0.26 0.063 DB00624 0.329 0.041 DBMET00558 0.465 0.016 DBMET00593 0.346 0.036 DBMET00571 0.52 0.011 DBMET02832 0.52 0.011 DBMET02833 0.52 0.011 DBMET02834 | DBMET02834 | |
| 0.326 | 0.004 | 0.579 | Pregnane X receptor agonist | 0.519 0.002 DB00624 0.579 0.002 DBMET00558 0.137 0.08 DBMET00593 0.146 0.06 DBMET00571 0.439 0.003 DBMET00574 0.533 0.002 DBMET02832 0.533 0.002 DBMET02833 0.533 0.002 DBMET02834 | DBMET00558 | |
| 0.326 | 0.005 | 0.484 | Farnesoid X receptor antagonist | 0.376 0.004 DB00624 0.408 0.004 DBMET00558 0.305 0.005 DBMET00593 0.229 0.015 DBMET00571 0.292 0.006 DBMET00574 0.484 0.003 DBMET02832 0.484 0.003 DBMET02833 0.484 0.003 DBMET02834 | DBMET02834 | |
| 0.334 | 0.015 | 0.334 | Gastrin inhibitor | 0.276 0.052 DB00624 0.293 0.038 DBMET00558 0.226 0.11 DBMET00593 0.26 0.068 DBMET00571 0.19 0.164 DBMET00574 0.262 0.066 DBMET02832 0.262 0.066 DBMET02833 0.262 0.066 DBMET02834 | ||
| 0.318 | 0.001 | 0.329 | Arachidonic acid antagonist | 0.329 0.001 DB00624 0.317 0.001 DBMET00558 0.24 0.008 DBMET00593 0.264 0.004 DBMET00571 0.272 0.003 DBMET00574 0.291 0.002 DBMET02832 0.291 0.002 DBMET02833 0.291 0.002 DBMET02834 | DB00624 | |
| 0.32 | 0.003 | 0.551 | Progesterone antagonist | 0.551 0.002 DB00624 0.393 0.003 DBMET00558 0.044 0.02 DBMET00574 0.291 0.004 DBMET02832 0.291 0.004 DBMET02833 0.291 0.004 DBMET02834 | DB00624 | |
| 0.346 | 0.034 | 0.824 | Angiogenesis stimulant | 0.375 0.026 DB00624 0.356 0.031 DBMET00558 0.824 0.004 DBMET00593 0.772 0.004 DBMET00571 0.771 0.004 DBMET00574 0.426 0.018 DBMET02832 0.426 0.018 DBMET02833 0.426 0.018 DBMET02834 | DBMET00593 | |
| 0.312 | 0.002 | 0.498 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.498 0.002 DB00624 0.378 0.002 DBMET00558 0.031 0.024 DBMET00593 0.064 0.007 DBMET00574 0.414 0.002 DBMET02832 0.414 0.002 DBMET02833 0.414 0.002 DBMET02834 | DB00624 | |
| 0.324 | 0.019 | 0.42 | Melanin inhibitor | 0.42 0.01 DB00624 0.211 0.037 DBMET00558 0.325 0.019 DBMET00593 0.345 0.017 DBMET00571 0.183 0.049 DBMET02832 0.183 0.049 DBMET02833 0.183 0.049 DBMET02834 | DB00624 | |
| 0.335 | 0.034 | 0.668 | Interleukin agonist | 0.455 0.012 DB00624 0.415 0.017 DBMET00558 0.668 0.004 DBMET00593 0.585 0.005 DBMET00571 0.496 0.009 DBMET02832 0.496 0.009 DBMET02833 0.496 0.009 DBMET02834 | DBMET00593 | |
| 0.343 | 0.048 | 0.673 | Antioxidant | 0.427 0.03 DB00624 0.423 0.031 DBMET00558 0.673 0.007 DBMET00593 0.656 0.008 DBMET00571 0.468 0.024 DBMET00574 0.472 0.023 DBMET02832 0.472 0.023 DBMET02833 0.472 0.023 DBMET02834 | DBMET00593 | |
| 0.296 | 0.014 | 0.451 | Adenylate cyclase inhibitor | 0.451 0.006 DB00624 0.329 0.011 DBMET00558 0.208 0.024 DBMET00593 0.177 0.031 DBMET00571 0.313 0.012 DBMET02832 0.313 0.012 DBMET02833 0.313 0.012 DBMET02834 | DB00624 | |
| 0.341 | 0.068 | 0.705 | Antithrombotic | 0.266 0.114 DB00624 0.269 0.111 DBMET00558 0.705 0.008 DBMET00593 0.621 0.014 DBMET00571 0.472 0.033 DBMET00574 0.322 0.076 DBMET02832 0.322 0.076 DBMET02833 0.322 0.076 DBMET02834 | DBMET00593 | |
| 0.26 | 0.006 | 0.272 | Microtubule formation inhibitor | 0.26 0.006 DB00624 0.267 0.005 DBMET00558 0.272 0.004 DBMET00593 0.266 0.005 DBMET00571 0.135 0.047 DBMET00574 0.268 0.005 DBMET02832 0.268 0.005 DBMET02833 0.268 0.005 DBMET02834 | DBMET00593 | |
| 0.308 | 0.067 | 0.358 | Spasmolytic | 0.208 0.113 DBMET00558 0.358 0.05 DBMET00593 0.256 0.089 DBMET00571 0.223 0.104 DBMET02832 0.223 0.104 DBMET02833 0.223 0.104 DBMET02834 | DBMET00593 | |
| 0.334 | 0.095 | 0.525 | Antiobesity | 0.245 0.161 DB00624 0.308 0.111 DBMET00558 0.496 0.038 DBMET00593 0.235 0.171 DBMET00571 0.237 0.169 DBMET00574 0.525 0.032 DBMET02832 0.525 0.032 DBMET02833 0.525 0.032 DBMET02834 | DBMET02834 | |
| 0.241 | 0.004 | 0.539 | Estrogen receptor alpha agonist | 0.516 0.002 DB00624 0.502 0.002 DBMET00558 0.193 0.005 DBMET00593 0.137 0.005 DBMET00571 0.22 0.004 DBMET00574 0.539 0.002 DBMET02832 0.539 0.002 DBMET02833 0.539 0.002 DBMET02834 | DBMET02834 | |
| 0.34 | 0.108 | 0.69 | Antibacterial | 0.325 0.117 DB00624 0.422 0.067 DBMET00558 0.658 0.012 DBMET00593 0.69 0.009 DBMET00571 0.496 0.042 DBMET00574 0.386 0.083 DBMET02832 0.386 0.083 DBMET02833 0.386 0.083 DBMET02834 | DBMET00571 | |
| 0.244 | 0.018 | 0.308 | DNA polymerase I inhibitor | 0.294 0.012 DB00624 0.272 0.014 DBMET00558 0.257 0.016 DBMET00593 0.242 0.018 DBMET00571 0.172 0.038 DBMET00574 0.308 0.011 DBMET02832 0.308 0.011 DBMET02833 0.308 0.011 DBMET02834 | DBMET02834 | |
| 0.25 | 0.025 | 0.258 | Bone formation stimulant | 0.258 0.023 DB00624 0.249 0.025 DBMET00558 0.164 0.049 DBMET00593 0.159 0.052 DBMET00571 0.253 0.024 DBMET02832 0.253 0.024 DBMET02833 0.253 0.024 DBMET02834 | DB00624 | |
| 0.24 | 0.029 | 0.317 | Protein kinase stimulant | 0.202 0.041 DB00624 0.174 0.053 DBMET00558 0.317 0.015 DBMET00593 0.268 0.022 DBMET00571 0.234 0.031 DBMET02832 0.234 0.031 DBMET02833 0.234 0.031 DBMET02834 | DBMET00593 | |
| 0.249 | 0.039 | 0.553 | Neurotrophic factor enhancer | 0.338 0.011 DB00624 0.553 0.003 DBMET00558 0.379 0.007 DBMET00593 0.512 0.004 DBMET00571 0.238 0.045 DBMET00574 0.498 0.004 DBMET02832 0.498 0.004 DBMET02833 0.498 0.004 DBMET02834 | DBMET00558 | |
| 0.217 | 0.008 | 0.508 | Estrogen receptor beta antagonist | 0.503 0.004 DB00624 0.508 0.004 DBMET00558 0.124 0.028 DBMET00593 0.129 0.024 DBMET00571 0.176 0.012 DBMET00574 0.475 0.004 DBMET02832 0.475 0.004 DBMET02833 0.475 0.004 DBMET02834 | DBMET00558 | |
| 0.211 | 0.004 | 0.376 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.376 0.002 DB00624 0.254 0.003 DBMET00558 0.126 0.007 DBMET00574 0.237 0.003 DBMET02832 0.237 0.003 DBMET02833 0.237 0.003 DBMET02834 | DB00624 | |
| 0.207 | 0.004 | 0.395 | Mineralocorticoid receptor antagonist | 0.395 0.003 DB00624 0.209 0.004 DBMET00558 0.043 0.042 DBMET00593 0.056 0.023 DBMET00571 0.083 0.01 DBMET00574 0.148 0.005 DBMET02832 0.148 0.005 DBMET02833 0.148 0.005 DBMET02834 | DB00624 | |
| 0.228 | 0.03 | 0.686 | Phospholipase C inhibitor | 0.388 0.011 DB00624 0.567 0.004 DBMET00558 0.488 0.006 DBMET00593 0.313 0.017 DBMET00571 0.544 0.005 DBMET00574 0.686 0.003 DBMET02832 0.686 0.003 DBMET02833 0.686 0.003 DBMET02834 | DBMET02834 | |
| 0.202 | 0.005 | 0.523 | Estrogen receptor beta agonist | 0.517 0.003 DB00624 0.523 0.003 DBMET00558 0.218 0.004 DBMET00593 0.218 0.004 DBMET00571 0.365 0.003 DBMET00574 0.522 0.003 DBMET02832 0.522 0.003 DBMET02833 0.522 0.003 DBMET02834 | DBMET00558 | |
| 0.209 | 0.012 | 0.214 | Acetylcholine nicotinic antagonist | 0.134 0.025 DB00624 0.138 0.024 DBMET00558 0.214 0.012 DBMET02832 0.214 0.012 DBMET02833 0.214 0.012 DBMET02834 | DBMET02834 | |
| 0.196 | 0.003 | 0.324 | Glucocorticoid antagonist | 0.324 0.002 DB00624 0.213 0.003 DBMET00558 0.071 0.008 DBMET00593 0.084 0.006 DBMET00571 0.102 0.005 DBMET00574 0.205 0.003 DBMET02832 0.205 0.003 DBMET02833 0.205 0.003 DBMET02834 | DB00624 | |
| 0.196 | 0.004 | 0.396 | Glycine receptor antagonist | 0.262 0.002 DB00624 0.236 0.003 DBMET00558 0.314 0.002 DBMET00593 0.264 0.002 DBMET00571 0.396 0.001 DBMET00574 0.276 0.002 DBMET02832 0.276 0.002 DBMET02833 0.276 0.002 DBMET02834 | DBMET00574 | |
| 0.267 | 0.076 | 0.879 | Aldehyde oxidase inhibitor | 0.879 0.004 DB00624 0.788 0.005 DBMET00558 0.214 0.097 DBMET00593 0.204 0.102 DBMET00574 0.794 0.004 DBMET02832 0.794 0.004 DBMET02833 0.794 0.004 DBMET02834 | DB00624 | |
| 0.223 | 0.033 | 0.356 | Lipid peroxidase inhibitor | 0.306 0.018 DB00624 0.21 0.037 DBMET00558 0.356 0.012 DBMET00593 0.355 0.012 DBMET00571 0.131 0.083 DBMET00574 0.231 0.031 DBMET02832 0.231 0.031 DBMET02833 0.231 0.031 DBMET02834 | DBMET00593 | |
| 0.26 | 0.071 | 0.652 | Hypoglycemic | 0.205 0.107 DB00624 0.252 0.075 DBMET00558 0.652 0.006 DBMET00593 0.616 0.007 DBMET00571 0.286 0.058 DBMET02832 0.286 0.058 DBMET02833 0.286 0.058 DBMET02834 | DBMET00593 | |
| 0.216 | 0.028 | 0.216 | Cholinergic antagonist | 0.117 0.076 DB00624 0.125 0.069 DBMET00558 0.184 0.037 DBMET02832 0.184 0.037 DBMET02833 0.184 0.037 DBMET02834 | ||
| 0.19 | 0.003 | 0.365 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.365 0.002 DB00624 0.238 0.003 DBMET00558 0.21 0.003 DBMET00593 0.187 0.003 DBMET00571 0.037 0.012 DBMET00574 0.228 0.003 DBMET02832 0.228 0.003 DBMET02833 0.228 0.003 DBMET02834 | DB00624 | |
| 0.212 | 0.028 | 0.212 | Acetylcholine antagonist | 0.115 0.075 DB00624 0.123 0.068 DBMET00558 0.181 0.036 DBMET02832 0.181 0.036 DBMET02833 0.181 0.036 DBMET02834 | ||
| 0.212 | 0.03 | 0.352 | Insulin secretagoues | 0.352 0.008 DBMET00593 0.264 0.017 DBMET00571 0.207 0.032 DBMET02832 0.207 0.032 DBMET02833 0.207 0.032 DBMET02834 | DBMET00593 | |
| 0.206 | 0.025 | 0.503 | Alkylator | 0.314 0.012 DB00624 0.251 0.016 DBMET00558 0.503 0.005 DBMET00593 0.404 0.007 DBMET00571 0.186 0.03 DBMET00574 0.343 0.01 DBMET02832 0.343 0.01 DBMET02833 0.343 0.01 DBMET02834 | DBMET00593 | |
| 0.231 | 0.051 | 0.377 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.377 0.009 DB00624 0.336 0.015 DBMET00558 0.157 0.134 DBMET00593 0.212 0.063 DBMET00571 0.265 0.036 DBMET02832 0.265 0.036 DBMET02833 0.265 0.036 DBMET02834 | DB00624 | |
| 0.18 | 0.003 | 0.34 | Na+ K+ transporting ATPase inhibitor | 0.2 0.002 DB00624 0.236 0.002 DBMET00558 0.34 0.001 DBMET00593 0.309 0.001 DBMET00571 0.217 0.002 DBMET00574 0.225 0.002 DBMET02832 0.225 0.002 DBMET02833 0.225 0.002 DBMET02834 | DBMET00593 | |
| 0.268 | 0.098 | 0.561 | Caspase 3 stimulant | 0.432 0.035 DB00624 0.467 0.026 DBMET00558 0.522 0.017 DBMET00593 0.437 0.033 DBMET00571 0.561 0.013 DBMET02832 0.561 0.013 DBMET02833 0.561 0.013 DBMET02834 | DBMET02834 | |
| 0.224 | 0.055 | 0.224 | Sigma receptor agonist | 0.155 0.082 DB00624 | ||
| 0.24 | 0.074 | 0.501 | DNA synthesis inhibitor | 0.344 0.031 DB00624 0.34 0.033 DBMET00558 0.501 0.013 DBMET00593 0.484 0.015 DBMET00571 0.213 0.104 DBMET00574 0.383 0.024 DBMET02832 0.383 0.024 DBMET02833 0.383 0.024 DBMET02834 | DBMET00593 | |
| 0.176 | 0.011 | 0.176 | Toll-Like receptor 4 antagonist | 0.146 0.023 DB00624 0.095 0.078 DBMET00558 0.161 0.016 DBMET00593 0.159 0.016 DBMET00571 0.103 0.064 DBMET02832 0.103 0.064 DBMET02833 0.103 0.064 DBMET02834 | ||
| 0.181 | 0.025 | 0.284 | Adenylate cyclase stimulant | 0.253 0.004 DB00624 0.261 0.004 DBMET00558 0.212 0.009 DBMET00593 0.176 0.029 DBMET00571 0.235 0.005 DBMET00574 0.284 0.003 DBMET02832 0.284 0.003 DBMET02833 0.284 0.003 DBMET02834 | DBMET02834 | |
| 0.161 | 0.006 | 0.267 | Glycine receptor agonist | 0.264 0.003 DB00624 0.194 0.004 DBMET00558 0.223 0.004 DBMET00593 0.178 0.005 DBMET00571 0.096 0.023 DBMET00574 0.267 0.003 DBMET02832 0.267 0.003 DBMET02833 0.267 0.003 DBMET02834 | DBMET02834 | |
| 0.157 | 0.003 | 0.202 | Progesterone agonist | 0.202 0.002 DB00624 0.157 0.003 DBMET00558 0.033 0.006 DBMET00593 0.048 0.005 DBMET00571 0.071 0.004 DBMET00574 0.132 0.003 DBMET02832 0.132 0.003 DBMET02833 0.132 0.003 DBMET02834 | DB00624 | |
| 0.194 | 0.044 | 0.4 | Interleukin 6 antagonist | 0.26 0.021 DB00624 0.302 0.014 DBMET00558 0.4 0.007 DBMET00593 0.335 0.011 DBMET00571 0.32 0.012 DBMET02832 0.32 0.012 DBMET02833 0.32 0.012 DBMET02834 | DBMET00593 | |
| 0.228 | 0.079 | 0.517 | Free radical scavenger | 0.26 0.064 DB00624 0.194 0.102 DBMET00558 0.517 0.015 DBMET00593 0.478 0.018 DBMET00571 0.207 0.092 DBMET02832 0.207 0.092 DBMET02833 0.207 0.092 DBMET02834 | DBMET00593 | |
| 0.175 | 0.03 | 0.349 | Cyclooxygenase 3 inhibitor | 0.152 0.047 DB00624 0.166 0.036 DBMET00558 0.349 0.005 DBMET00593 0.317 0.005 DBMET00571 0.153 0.046 DBMET02832 0.153 0.046 DBMET02833 0.153 0.046 DBMET02834 | DBMET00593 | |
| 0.141 | 0.004 | 0.229 | Estrone sulfatase inhibitor | 0.166 0.003 DB00624 0.163 0.003 DBMET00558 0.04 0.009 DBMET00593 0.046 0.008 DBMET00571 0.229 0.002 DBMET00574 0.161 0.003 DBMET02832 0.161 0.003 DBMET02833 0.161 0.003 DBMET02834 | DBMET00574 | |
| 0.157 | 0.021 | 0.267 | Hedgehog signaling inhibitor | 0.267 0.005 DB00624 0.135 0.03 DBMET00558 0.105 0.056 DBMET00571 0.234 0.008 DBMET02832 0.234 0.008 DBMET02833 0.234 0.008 DBMET02834 | DB00624 | |
| 0.212 | 0.077 | 0.378 | Antimitotic | 0.344 0.034 DB00624 0.378 0.027 DBMET00558 0.162 0.11 DBMET00593 0.234 0.066 DBMET00574 0.342 0.034 DBMET02832 0.342 0.034 DBMET02833 0.342 0.034 DBMET02834 | DBMET00558 | |
| 0.221 | 0.087 | 0.299 | Platelet antagonist | 0.299 0.053 DBMET00593 0.234 0.08 DBMET00571 | DBMET00593 | |
| 0.127 | 0.003 | 0.144 | Lipocortins synthesis agonist | 0.144 0.002 DB00624 0.132 0.002 DBMET00558 0.111 0.004 DBMET00593 0.114 0.004 DBMET00571 0.111 0.004 DBMET00574 0.128 0.003 DBMET02832 0.128 0.003 DBMET02833 0.128 0.003 DBMET02834 | DB00624 | |
| 0.151 | 0.028 | 0.558 | AMP-activated protein kinase stimulant | 0.291 0.005 DB00624 0.152 0.027 DBMET00558 0.558 0.003 DBMET00593 0.289 0.005 DBMET00571 0.221 0.009 DBMET02832 0.221 0.009 DBMET02833 0.221 0.009 DBMET02834 | DBMET00593 | |
| 0.135 | 0.022 | 0.163 | ABCA1 expression enhancer | 0.157 0.016 DB00624 0.102 0.047 DBMET00558 0.163 0.014 DBMET02832 0.163 0.014 DBMET02833 0.163 0.014 DBMET02834 | DBMET02834 | |
| 0.107 | 0.003 | 0.126 | Pregnane X receptor antagonist | 0.126 0.002 DB00624 0.094 0.004 DBMET00558 0.091 0.004 DBMET02832 0.091 0.004 DBMET02833 0.091 0.004 DBMET02834 | DB00624 | |
| 0.152 | 0.063 | 0.455 | Amylase inhibitor | 0.359 0.012 DB00624 0.193 0.047 DBMET00558 0.455 0.007 DBMET00593 0.349 0.013 DBMET00571 0.259 0.026 DBMET02832 0.259 0.026 DBMET02833 0.259 0.026 DBMET02834 | DBMET00593 | |
| 0.142 | 0.053 | 0.213 | Anesthetic local | 0.134 0.057 DB00624 0.164 0.043 DBMET00558 0.213 0.029 DBMET02832 0.213 0.029 DBMET02833 0.213 0.029 DBMET02834 | DBMET02834 | |
| 0.119 | 0.038 | 0.218 | Antineoplastic alkaloid | 0.126 0.035 DB00624 0.218 0.009 DBMET00558 0.096 0.05 DBMET00571 0.197 0.014 DBMET02832 0.197 0.014 DBMET02833 0.197 0.014 DBMET02834 | DBMET00558 | |
| 0.227 | 0.147 | 0.354 | Vasodilator, peripheral | 0.288 0.103 DB00624 0.269 0.114 DBMET00558 0.351 0.073 DBMET00593 0.205 0.17 DBMET00571 0.354 0.072 DBMET02832 0.354 0.072 DBMET02833 0.354 0.072 DBMET02834 | DBMET02834 | |
| 0.079 | 0.004 | 0.622 | Glucose-6-phosphate dehydrogenase inhibitor | 0.113 0.003 DB00624 0.203 0.002 DBMET00558 0.094 0.003 DBMET00593 0.088 0.003 DBMET00571 0.116 0.003 DBMET00574 0.622 0.001 DBMET02832 0.622 0.001 DBMET02833 0.622 0.001 DBMET02834 | DBMET02834 | |
| 0.08 | 0.005 | 0.209 | Farnesoid X receptor agonist | 0.085 0.005 DB00624 0.132 0.003 DBMET00558 0.053 0.013 DBMET00593 0.111 0.004 DBMET00574 0.209 0.002 DBMET02832 0.209 0.002 DBMET02833 0.209 0.002 DBMET02834 | DBMET02834 | |
| 0.141 | 0.068 | 0.3 | Neurotrophic factor | 0.175 0.041 DB00624 0.203 0.026 DBMET00558 0.192 0.031 DBMET00593 0.14 0.068 DBMET00571 0.3 0.008 DBMET02832 0.3 0.008 DBMET02833 0.3 0.008 DBMET02834 | DBMET02834 | |
| 0.096 | 0.023 | 0.317 | Beta tubulin antagonist | 0.298 0.005 DB00624 0.317 0.005 DBMET00558 0.05 0.047 DBMET00593 0.143 0.013 DBMET00574 0.298 0.005 DBMET02832 0.298 0.005 DBMET02833 0.298 0.005 DBMET02834 | DBMET00558 | |
| 0.099 | 0.028 | 0.259 | CDC25A inhibitor | 0.116 0.02 DB00624 0.176 0.009 DBMET00558 0.098 0.028 DBMET00593 0.087 0.036 DBMET00571 0.259 0.004 DBMET00574 0.201 0.007 DBMET02832 0.201 0.007 DBMET02833 0.201 0.007 DBMET02834 | DBMET00574 | |
| 0.087 | 0.017 | 0.087 | Nitric oxide donor | 0.071 0.032 DB00624 0.082 0.02 DBMET00593 0.068 0.035 DBMET00571 0.072 0.031 DBMET02832 0.072 0.031 DBMET02833 0.072 0.031 DBMET02834 | ||
| 0.072 | 0.003 | 0.124 | Glucocorticoid agonist | 0.124 0.002 DB00624 0.062 0.004 DBMET00558 0.013 0.009 DBMET00593 0.018 0.008 DBMET00571 0.038 0.005 DBMET00574 0.063 0.004 DBMET02832 0.063 0.004 DBMET02833 0.063 0.004 DBMET02834 | DB00624 | |
| 0.068 | 0.002 | 0.097 | Corticosteroid-like | 0.097 0.002 DB00624 0.05 0.003 DBMET00558 0.038 0.004 DBMET00593 0.04 0.004 DBMET00571 0.031 0.006 DBMET00574 0.051 0.003 DBMET02832 0.051 0.003 DBMET02833 0.051 0.003 DBMET02834 | DB00624 | |
| 0.069 | 0.005 | 0.29 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.29 0.002 DB00624 0.186 0.003 DBMET00558 0.019 0.018 DBMET00574 0.091 0.004 DBMET02832 0.091 0.004 DBMET02833 0.091 0.004 DBMET02834 | DB00624 | |
| 0.107 | 0.043 | 0.301 | Antineoplastic antibiotic | 0.144 0.032 DB00624 0.174 0.026 DBMET00558 0.301 0.009 DBMET00593 0.29 0.01 DBMET00571 0.13 0.036 DBMET00574 0.176 0.025 DBMET02832 0.176 0.025 DBMET02833 0.176 0.025 DBMET02834 | DBMET00593 | |
| 0.142 | 0.079 | 0.406 | Hemostatic | 0.406 0.007 DBMET00593 0.39 0.008 DBMET00571 0.358 0.011 DBMET00574 0.119 0.116 DBMET02832 0.119 0.116 DBMET02833 0.119 0.116 DBMET02834 | DBMET00593 | |
| 0.113 | 0.05 | 0.113 | Bronchodilator | 0.088 0.077 DBMET02832 0.088 0.077 DBMET02833 0.088 0.077 DBMET02834 | ||
| 0.191 | 0.129 | 0.464 | 5 Hydroxytryptamine release stimulant | 0.324 0.063 DB00624 0.381 0.05 DBMET00558 0.464 0.033 DBMET00593 0.418 0.042 DBMET00571 0.459 0.034 DBMET02832 0.459 0.034 DBMET02833 0.459 0.034 DBMET02834 | DBMET00593 | |
| 0.143 | 0.082 | 0.143 | Acetylcholine M1 receptor antagonist | 0.116 0.115 DBMET02832 0.116 0.115 DBMET02833 0.116 0.115 DBMET02834 | ||
| 0.063 | 0.002 | 0.122 | Hedgehog signaling activator | 0.066 0.002 DB00624 0.065 0.002 DBMET00558 0.031 0.011 DBMET00593 0.029 0.015 DBMET00574 0.122 0.001 DBMET02832 0.122 0.001 DBMET02833 0.122 0.001 DBMET02834 | DBMET02834 | |
| 0.076 | 0.018 | 0.1 | Heme oxygenase stimulant | 0.1 0.007 DB00624 0.096 0.008 DBMET00558 0.072 0.023 DBMET00593 0.073 0.022 DBMET00571 0.073 0.021 DBMET00574 0.098 0.008 DBMET02832 0.098 0.008 DBMET02833 0.098 0.008 DBMET02834 | DB00624 | |
| 0.118 | 0.06 | 0.121 | Photosensitizer | 0.121 0.056 DBMET00593 0.114 0.065 DBMET00571 | DBMET00593 | |
| 0.066 | 0.009 | 0.083 | Microtubule stabilization | 0.071 0.006 DB00624 0.078 0.004 DBMET00558 0.072 0.006 DBMET00593 0.064 0.01 DBMET00571 0.083 0.004 DBMET02832 0.083 0.004 DBMET02833 0.083 0.004 DBMET02834 | DBMET02834 | |
| 0.106 | 0.049 | 0.218 | Prolactin inhibitor | 0.14 0.027 DB00624 0.176 0.014 DBMET00558 0.218 0.006 DBMET02832 0.218 0.006 DBMET02833 0.218 0.006 DBMET02834 | DBMET02834 | |
| 0.1 | 0.045 | 0.126 | Ornithine decarboxylase inhibitor | 0.126 0.022 DB00624 0.124 0.023 DBMET00558 0.08 0.068 DBMET00593 0.097 0.048 DBMET00571 0.107 0.037 DBMET02832 0.107 0.037 DBMET02833 0.107 0.037 DBMET02834 | DB00624 | |
| 0.091 | 0.039 | 0.17 | Estrogen-related receptor beta agonist | 0.17 0.003 DB00624 0.153 0.004 DBMET00558 0.08 0.066 DBMET00593 0.17 0.003 DBMET02832 0.17 0.003 DBMET02833 0.17 0.003 DBMET02834 | DBMET02834 | |
| 0.181 | 0.131 | 0.488 | RNA-directed DNA polymerase inhibitor | 0.26 0.044 DB00624 0.332 0.026 DBMET00558 0.276 0.038 DBMET00593 0.308 0.03 DBMET00571 0.488 0.012 DBMET00574 0.294 0.033 DBMET02832 0.294 0.033 DBMET02833 0.294 0.033 DBMET02834 | DBMET00574 | |
| 0.117 | 0.07 | 0.117 | Acetylcholine muscarinic antagonist | 0.096 0.095 DBMET02832 0.096 0.095 DBMET02833 0.096 0.095 DBMET02834 | ||
| 0.087 | 0.041 | 0.256 | Keratolytic | 0.256 0.005 DB00624 0.213 0.007 DBMET00558 0.252 0.005 DBMET02832 0.252 0.005 DBMET02833 0.252 0.005 DBMET02834 | DB00624 | |
| 0.09 | 0.047 | 0.126 | Inducible nitric-oxide synthase inhibitor | 0.126 0.022 DB00624 0.088 0.05 DBMET00558 0.078 0.066 DBMET00574 0.084 0.055 DBMET02832 0.084 0.055 DBMET02833 0.084 0.055 DBMET02834 | DB00624 | |
| 0.11 | 0.069 | 0.285 | Monophenol monooxygenase inhibitor | 0.203 0.033 DB00624 0.108 0.07 DBMET00558 0.228 0.027 DBMET00593 0.285 0.019 DBMET00571 | DBMET00571 | |
| 0.092 | 0.052 | 0.092 | Interleukin 5 antagonist | |||
| 0.18 | 0.14 | 0.61 | Cardiotonic | 0.294 0.059 DB00624 0.444 0.022 DBMET00558 0.399 0.029 DBMET00593 0.195 0.123 DBMET00571 0.61 0.007 DBMET02832 0.61 0.007 DBMET02833 0.61 0.007 DBMET02834 | DBMET02834 | |
| 0.197 | 0.158 | 0.255 | 5 Hydroxytryptamine uptake stimulant | 0.245 0.086 DB00624 0.235 0.096 DBMET00558 0.255 0.076 DBMET02832 0.255 0.076 DBMET02833 0.255 0.076 DBMET02834 | DBMET02834 | |
| 0.065 | 0.027 | 0.291 | Alpha tubulin antagonist | 0.243 0.005 DB00624 0.286 0.004 DBMET00558 0.056 0.034 DBMET00593 0.169 0.008 DBMET00574 0.291 0.004 DBMET02832 0.291 0.004 DBMET02833 0.291 0.004 DBMET02834 | DBMET02834 | |
| 0.118 | 0.082 | 0.263 | Tubulin antagonist | 0.263 0.024 DB00624 0.249 0.025 DBMET00558 0.162 0.053 DBMET00574 0.198 0.037 DBMET02832 0.198 0.037 DBMET02833 0.198 0.037 DBMET02834 | DB00624 | |
| 0.116 | 0.082 | 0.116 | Acetylcholinesterase inhibitor | |||
| 0.043 | 0.012 | 0.064 | HMG CoA reductase inhibitor | 0.039 0.016 DB00624 0.039 0.015 DBMET00558 0.034 0.025 DBMET00593 0.064 0.004 DBMET02832 0.064 0.004 DBMET02833 0.064 0.004 DBMET02834 | DBMET02834 | |
| 0.049 | 0.024 | 0.078 | Liver X receptor agonist | 0.078 0.011 DB00624 0.057 0.018 DBMET02832 0.057 0.018 DBMET02833 0.057 0.018 DBMET02834 | DB00624 | |
| 0.057 | 0.033 | 0.138 | Protein 50S ribosomal subunit inhibitor | 0.053 0.037 DBMET00558 0.138 0.007 DBMET00593 0.135 0.008 DBMET00571 0.052 0.038 DBMET02832 0.052 0.038 DBMET02833 0.052 0.038 DBMET02834 | DBMET00593 | |
| 0.08 | 0.058 | 0.122 | Opioid kappa receptor antagonist | 0.073 0.071 DB00624 0.122 0.023 DBMET00558 | DBMET00558 | |
| 0.041 | 0.019 | 0.052 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.042 0.018 DB00624 0.037 0.025 DBMET00558 0.052 0.01 DBMET02832 0.052 0.01 DBMET02833 0.052 0.01 DBMET02834 | DBMET02834 | |
| 0.107 | 0.086 | 0.357 | Aldehyde dehydrogenase inhibitor | 0.357 0.007 DB00624 0.203 0.027 DBMET00558 0.181 0.033 DBMET00593 0.136 0.057 DBMET00571 0.236 0.02 DBMET02832 0.236 0.02 DBMET02833 0.236 0.02 DBMET02834 | DB00624 | |
| 0.023 | 0.002 | 0.029 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.029 0.002 DB00624 0.025 0.002 DBMET00558 0.013 0.008 DBMET00593 0.015 0.005 DBMET00571 0.018 0.003 DBMET00574 0.021 0.003 DBMET02832 0.021 0.003 DBMET02833 0.021 0.003 DBMET02834 | DB00624 | |
| 0.045 | 0.024 | 0.125 | Liver X receptor alpha agonist | 0.125 0.005 DB00624 0.039 0.031 DBMET00558 0.084 0.006 DBMET02832 0.084 0.006 DBMET02833 0.084 0.006 DBMET02834 | DB00624 | |
| 0.132 | 0.111 | 0.166 | Ca2+-transporting ATPase inhibitor | 0.153 0.036 DB00624 0.159 0.026 DBMET00558 0.163 0.019 DBMET00593 0.156 0.031 DBMET00571 0.166 0.016 DBMET02832 0.166 0.016 DBMET02833 0.166 0.016 DBMET02834 | DBMET02834 | |
| 0.021 | 0.001 | 0.459 | Transcortin receptor antagonist | 0.459 0 DB00624 0.35 0 DBMET00558 0.009 0.003 DBMET00593 0.012 0.002 DBMET00571 0.019 0.001 DBMET00574 0.201 0 DBMET02832 0.201 0 DBMET02833 0.201 0 DBMET02834 | DB00624 | |
| 0.036 | 0.016 | 0.036 | ATP citrate lysase inhibitor | 0.031 0.024 DB00624 | ||
| 0.126 | 0.107 | 0.126 | Phospholipase A2 inhibitor | |||
| 0.082 | 0.063 | 0.082 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.027 | 0.009 | 0.057 | Vitamin D receptor antagonist | 0.029 0.008 DB00624 0.03 0.007 DBMET00558 0.025 0.01 DBMET00593 0.024 0.011 DBMET00571 0.057 0.004 DBMET02832 0.057 0.004 DBMET02833 0.057 0.004 DBMET02834 | DBMET02834 | |
| 0.081 | 0.063 | 0.081 | T cell inhibitor | 0.081 0.06 DBMET00558 0.08 0.064 DBMET00571 | ||
| 0.022 | 0.005 | 0.07 | Vitamin D receptor agonist | 0.022 0.006 DB00624 0.059 0.002 DBMET00558 0.03 0.004 DBMET00593 0.034 0.003 DBMET00571 0.018 0.008 DBMET00574 0.07 0.002 DBMET02832 0.07 0.002 DBMET02833 0.07 0.002 DBMET02834 | DBMET02834 | |
| 0.046 | 0.032 | 0.114 | Adenylate cyclase 1 inhibitor | 0.114 0.003 DB00624 0.107 0.004 DBMET00558 0.109 0.004 DBMET02832 0.109 0.004 DBMET02833 0.109 0.004 DBMET02834 | DB00624 | |
| 0.025 | 0.012 | 0.025 | Prostaglandin F2 alpha agonist | 0.024 0.014 DBMET00558 0.021 0.019 DBMET02832 0.021 0.019 DBMET02833 0.021 0.019 DBMET02834 | ||
| 0.043 | 0.031 | 0.091 | Opioid kappa receptor agonist | 0.091 0.01 DBMET00558 0.039 0.035 DBMET00571 0.043 0.03 DBMET00574 0.053 0.022 DBMET02832 0.053 0.022 DBMET02833 0.053 0.022 DBMET02834 | DBMET00558 | |
| 0.032 | 0.02 | 0.032 | Prostaglandin D2 agonist | |||
| 0.15 | 0.141 | 0.473 | Growth factor agonist | 0.291 0.017 DB00624 0.473 0.005 DBMET00558 0.227 0.043 DBMET00593 0.284 0.019 DBMET00571 0.199 0.064 DBMET00574 0.362 0.007 DBMET02832 0.362 0.007 DBMET02833 0.362 0.007 DBMET02834 | DBMET00558 | |
| 0.094 | 0.085 | 0.227 | Protein-tyrosine phosphatase 1B inhibitor | 0.122 0.062 DB00624 0.183 0.034 DBMET00558 0.194 0.031 DBMET00593 0.182 0.034 DBMET00571 0.227 0.022 DBMET00574 0.195 0.031 DBMET02832 0.195 0.031 DBMET02833 0.195 0.031 DBMET02834 | DBMET00574 | |
| 0.044 | 0.035 | 0.221 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.081 0.015 DB00624 0.183 0.005 DBMET00558 0.045 0.035 DBMET00574 0.221 0.004 DBMET02832 0.221 0.004 DBMET02833 0.221 0.004 DBMET02834 | DBMET02834 | |
| 0.054 | 0.046 | 0.117 | Acetyl-CoA transferase 2 inhibitor | 0.053 0.048 DB00624 0.08 0.01 DBMET00558 0.067 0.021 DBMET00593 0.117 0.004 DBMET02832 0.117 0.004 DBMET02833 0.117 0.004 DBMET02834 | DBMET02834 | |
| 0.018 | 0.011 | 0.067 | Telomerase stimulant | 0.04 0.002 DB00624 0.042 0.002 DBMET00558 0.067 0.001 DBMET00593 0.053 0.001 DBMET00571 0.016 0.013 DBMET00574 0.047 0.001 DBMET02832 0.047 0.001 DBMET02833 0.047 0.001 DBMET02834 | DBMET00593 | |
| 0.057 | 0.051 | 0.057 | Prostaglandin F2 alpha antagonist | |||
| 0.033 | 0.027 | 0.053 | Tubulin agonist | 0.044 0.011 DB00624 0.053 0.007 DBMET00558 0.036 0.021 DBMET00593 0.034 0.025 DBMET00571 0.053 0.007 DBMET02832 0.053 0.007 DBMET02833 0.053 0.007 DBMET02834 | DBMET02834 | |
| 0.06 | 0.055 | 0.06 | Interferon inducer | |||
| 0.015 | 0.011 | 0.021 | Thromboxane A2 agonist | 0.015 0.012 DB00624 0.015 0.013 DBMET00558 0.021 0.005 DBMET02832 0.021 0.005 DBMET02833 0.021 0.005 DBMET02834 | DBMET02834 | |
| 0.071 | 0.068 | 0.071 | Interferon agonist | |||
| 0.042 | 0.04 | 0.147 | Potassium channel Kv1.3 blocker | 0.093 0.009 DB00624 0.147 0.004 DBMET00558 0.107 0.007 DBMET02832 0.107 0.007 DBMET02833 0.107 0.007 DBMET02834 | DBMET00558 | |
| 0.03 | 0.028 | 0.039 | Liver X receptor beta agonist | 0.039 0.016 DB00624 | DB00624 | |
| 0.008 | 0.009 | 0.028 | Progesterone receptor A antagonist | 0.028 0.003 DB00624 | DB00624 | |
| 0.076 | 0.079 | 0.242 | Transcription factor NF kappa B stimulant | 0.117 0.027 DB00624 0.143 0.018 DBMET00558 0.242 0.006 DBMET00593 0.197 0.009 DBMET00571 0.172 0.012 DBMET02832 0.172 0.012 DBMET02833 0.172 0.012 DBMET02834 | DBMET00593 | |
| 0.041 | 0.046 | 0.085 | Parathyroid hormone antagonist | 0.05 0.022 DB00624 0.054 0.016 DBMET00558 0.085 0.004 DBMET02832 0.085 0.004 DBMET02833 0.085 0.004 DBMET02834 | DBMET02834 | |
| 0.016 | 0.023 | 0.022 | Progesterone receptor B antagonist | 0.022 0.01 DB00624 | DB00624 | |
| 0.023 | 0.03 | 0.037 | Toll-Like receptor 4 agonist | 0.032 0.009 DBMET00593 0.03 0.011 DBMET00571 0.037 0.006 DBMET00574 | DBMET00574 | |
| 0.007 | 0.015 | 0.012 | Thromboxane agonist | 0.012 0.006 DBMET02832 0.012 0.006 DBMET02833 0.012 0.006 DBMET02834 | DBMET02834 | |
| 0.001 | 0.011 | 0.004 | Vitamin D-like | 0.004 0.003 DBMET02832 0.004 0.003 DBMET02833 0.004 0.003 DBMET02834 | DBMET02834 | |
| 0.116 | 0.128 | 0.306 | Growth hormone agonist | 0.277 0.037 DB00624 0.287 0.035 DBMET00558 0.306 0.031 DBMET02832 0.306 0.031 DBMET02833 0.306 0.031 DBMET02834 | DBMET02834 | |
| 0.173 | 0.197 | 0.449 | Immunomodulator | 0.205 0.158 DB00624 0.449 0.031 DBMET00593 0.367 0.054 DBMET00571 0.24 0.123 DBMET02832 0.24 0.123 DBMET02833 0.24 0.123 DBMET02834 | DBMET00593 | |
| 0.009 | 0.033 | 0.016 | NMDA receptor phencyclidine site antagonist | 0.016 0.01 DBMET02832 0.016 0.01 DBMET02833 0.016 0.01 DBMET02834 | DBMET02834 | |
| 0.004 | 0.029 | 0.019 | Antibiotic Macrolide-like | 0.019 0.007 DBMET00593 0.019 0.007 DBMET00571 | DBMET00571 | |
| 0.008 | 0.034 | 0.115 | Ileal bile acid transport inhibitor | 0.031 0.005 DB00624 0.063 0.003 DBMET00558 0.115 0.002 DBMET00593 0.066 0.003 DBMET00571 0.015 0.014 DBMET00574 0.115 0.002 DBMET02832 0.115 0.002 DBMET02833 0.115 0.002 DBMET02834 | DBMET02834 | |
| 0.014 | 0.043 | 0.028 | CYP24 inhibitor | 0.021 0.018 DB00624 0.028 0.011 DBMET02832 0.028 0.011 DBMET02833 0.028 0.011 DBMET02834 | DBMET02834 | |
| 0.139 | 0.174 | 0.392 | Vasodilator | 0.153 0.152 DBMET00558 0.392 0.024 DBMET00593 0.294 0.05 DBMET00571 0.239 0.076 DBMET02832 0.239 0.076 DBMET02833 0.239 0.076 DBMET02834 | DBMET00593 | |
| 0.125 | 0.161 | 0.312 | Non-steroidal antiinflammatory agent | 0.172 0.094 DBMET00558 0.284 0.032 DBMET00593 0.312 0.026 DBMET00571 | DBMET00571 | |
| 0.089 | 0.127 | 0.226 | Interleukin 8 antagonist | 0.226 0.008 DB00624 0.121 0.061 DBMET00558 | DB00624 | |
| 0.067 | 0.107 | 0.09 | Breast cancer-resistant protein inhibitor | 0.082 0.078 DB00624 0.085 0.072 DBMET00558 0.09 0.066 DBMET00574 | DBMET00574 | |
| 0.098 | 0.137 | 0.313 | Thrombolytic | 0.313 0.022 DBMET00593 0.237 0.037 DBMET00571 | DBMET00593 | |
| 0.033 | 0.076 | 0.056 | Cholesterol esterase inhibitor | 0.055 0.023 DBMET00558 0.056 0.021 DBMET02832 0.056 0.021 DBMET02833 0.056 0.021 DBMET02834 | DBMET02834 | |
| 0.189 | 0.232 | 0.425 | Calcium channel activator | 0.346 0.053 DB00624 0.425 0.017 DBMET00558 0.236 0.163 DBMET00574 0.388 0.029 DBMET02832 0.388 0.029 DBMET02833 0.388 0.029 DBMET02834 | DBMET00558 | |
| 0.014 | 0.059 | 0.072 | Protein 30S ribosomal subunit inhibitor | 0.072 0.005 DBMET00593 0.072 0.005 DBMET00571 | DBMET00571 | |
| 0.032 | 0.083 | 0.057 | Diacylglycerol O-acyltransferase inhibitor | 0.057 0.028 DBMET02832 0.057 0.028 DBMET02833 0.057 0.028 DBMET02834 | DBMET02834 | |
| 0.023 | 0.077 | 0.078 | GABA uptake inhibitor | 0.035 0.034 DB00624 0.058 0.011 DBMET00558 0.078 0.005 DBMET02832 0.078 0.005 DBMET02833 0.078 0.005 DBMET02834 | DBMET02834 | |
| 0.068 | 0.121 | 0.097 | Thioredoxin inhibitor | 0.097 0.052 DBMET00571 | DBMET00571 | |
| 0.021 | 0.079 | 0.048 | Estrogen-related receptor beta antagonist | 0.047 0.006 DB00624 0.042 0.009 DBMET00558 0.048 0.006 DBMET02832 0.048 0.006 DBMET02833 0.048 0.006 DBMET02834 | DBMET02834 | |
| 0.015 | 0.074 | 0.039 | Vanilloid 2 agonist | 0.039 0.004 DBMET00593 0.034 0.006 DBMET00571 0.025 0.019 DBMET02832 0.025 0.019 DBMET02833 0.025 0.019 DBMET02834 | DBMET00593 | |
| 0.016 | 0.076 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DBMET00593 0.029 0.017 DBMET00571 0.034 0.008 DBMET00574 | DBMET00574 | |
| 0.035 | 0.095 | 0.072 | Glucose-6-phosphate translocase inhibitor | 0.072 0.015 DBMET00593 0.068 0.017 DBMET00571 | DBMET00593 | |
| 0.061 | 0.123 | 0.098 | Alcohol dehydrogenase inhibitor | 0.098 0.055 DB00624 | DB00624 | |
| 0.051 | 0.117 | 0.065 | Calcium channel P-type blocker | 0.065 0.04 DB00624 | DB00624 | |
| 0.03 | 0.096 | 0.243 | GABA receptor antagonist | 0.062 0.03 DB00624 0.2 0.006 DBMET00558 0.242 0.005 DBMET00574 0.243 0.005 DBMET02832 0.243 0.005 DBMET02833 0.243 0.005 DBMET02834 | DBMET02834 | |
| 0.03 | 0.101 | 0.053 | Acetyl-CoA transferase inhibitor | 0.053 0.036 DBMET02832 0.053 0.036 DBMET02833 0.053 0.036 DBMET02834 | DBMET02834 | |
| 0.079 | 0.15 | 0.148 | Acetylcholine release stimulant | 0.106 0.073 DB00624 0.1 0.086 DBMET00571 0.148 0.018 DBMET00574 | DBMET00574 | |
| 0.09 | 0.165 | 0.322 | Protein-tyrosine phosphatase inhibitor | 0.122 0.111 DB00624 0.166 0.065 DBMET00558 0.171 0.062 DBMET00593 0.164 0.066 DBMET00571 0.322 0.015 DBMET00574 0.168 0.064 DBMET02832 0.168 0.064 DBMET02833 0.168 0.064 DBMET02834 | DBMET00574 | |
| 0.053 | 0.129 | 0.077 | Opioid antagonist | 0.077 0.074 DBMET00558 | DBMET00558 | |
| 0.033 | 0.124 | 0.131 | Botulinum neurotoxin type A inhibitor | 0.052 0.051 DB00624 0.123 0.006 DBMET00558 0.131 0.005 DBMET02832 0.131 0.005 DBMET02833 0.131 0.005 DBMET02834 | DBMET02834 | |
| 0.026 | 0.118 | 0.213 | GABA A receptor antagonist | 0.053 0.037 DB00624 0.166 0.007 DBMET00558 0.183 0.006 DBMET00574 0.213 0.005 DBMET02832 0.213 0.005 DBMET02833 0.213 0.005 DBMET02834 | DBMET02834 | |
| 0.026 | 0.119 | 0.129 | HIV-1 integrase (Strand Transfer) inhibitor | 0.129 0.015 DBMET00574 | DBMET00574 | |
| 0.009 | 0.108 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.011 DBMET00558 | DBMET00558 | |
| 0.019 | 0.119 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.025 DBMET02832 0.031 0.025 DBMET02833 0.031 0.025 DBMET02834 | DBMET02834 | |
| 0.006 | 0.107 | 0.044 | Arginase inhibitor | 0.044 0.019 DBMET00593 | DBMET00593 | |
| 0.014 | 0.117 | 0.037 | Estrogen-related receptor alpha antagonist | 0.032 0.023 DB00624 0.03 0.026 DBMET00558 0.037 0.019 DBMET02832 0.037 0.019 DBMET02833 0.037 0.019 DBMET02834 | DBMET02834 | |
| 0.062 | 0.169 | 0.083 | Hematopoietic | 0.083 0.064 DBMET00558 | DBMET00558 | |
| 0.052 | 0.161 | 0.511 | Expectorant | 0.103 0.065 DB00624 0.153 0.034 DBMET00558 0.511 0.004 DBMET00593 0.341 0.006 DBMET00571 0.239 0.014 DBMET02832 0.239 0.014 DBMET02833 0.239 0.014 DBMET02834 | DBMET00593 | |
| 0.038 | 0.153 | 0.071 | Epoxide hydrolase inhibitor | 0.071 0.052 DBMET02832 0.071 0.052 DBMET02833 0.071 0.052 DBMET02834 | DBMET02834 | |
| 0.06 | 0.179 | 0.207 | Mucolytic | 0.105 0.071 DB00624 0.144 0.036 DBMET00558 0.207 0.012 DBMET00593 0.147 0.034 DBMET00571 0.202 0.013 DBMET02832 0.202 0.013 DBMET02833 0.202 0.013 DBMET02834 | DBMET00593 | |
| 0.094 | 0.214 | 0.163 | Insulin sensitizer | 0.163 0.116 DBMET02832 0.163 0.116 DBMET02833 0.163 0.116 DBMET02834 | DBMET02834 | |
| 0.071 | 0.192 | 0.351 | Cell adhesion inhibitor | 0.262 0.013 DBMET00593 0.351 0.007 DBMET00571 0.11 0.074 DBMET00574 | DBMET00571 | |
| 0.138 | 0.26 | 0.376 | Vasodilator, coronary | 0.376 0.044 DBMET00593 0.289 0.097 DBMET00571 0.26 0.125 DBMET02832 0.26 0.125 DBMET02833 0.26 0.125 DBMET02834 | DBMET00593 | |
| 0.042 | 0.164 | 0.207 | Topoisomerase I inhibitor | 0.207 0.025 DBMET00593 0.187 0.03 DBMET00571 | DBMET00593 | |
| 0.043 | 0.17 | 0.082 | Glutamate (mGluR6) antagonist | 0.064 0.054 DB00624 0.066 0.047 DBMET00558 0.082 0.022 DBMET02832 0.082 0.022 DBMET02833 0.082 0.022 DBMET02834 | DBMET02834 | |
| 0.059 | 0.189 | 0.215 | Multidrug resistance-associated protein 1 inhibitor | 0.148 0.026 DBMET00593 0.181 0.015 DBMET00571 0.215 0.008 DBMET00574 | DBMET00574 | |
| 0.124 | 0.263 | 0.376 | Transcription factor STAT3 inhibitor | 0.246 0.087 DB00624 0.325 0.042 DBMET00558 0.288 0.059 DBMET00593 0.177 0.169 DBMET00571 0.376 0.025 DBMET02832 0.376 0.025 DBMET02833 0.376 0.025 DBMET02834 | DBMET02834 | |
| 0.016 | 0.159 | 0.075 | NMDA 2C receptor antagonist | 0.075 0.029 DBMET00574 | DBMET00574 | |
| 0.016 | 0.161 | 0.048 | Adenosine deaminase inhibitor | 0.048 0.032 DB00624 | DB00624 | |
| 0.052 | 0.205 | 0.191 | Lanosterol 14 alpha demethylase inhibitor | 0.113 0.038 DB00624 0.116 0.035 DBMET00558 0.191 0.005 DBMET02832 0.191 0.005 DBMET02833 0.191 0.005 DBMET02834 | DBMET02834 | |
| 0.024 | 0.177 | 0.121 | HIV-1 integrase (3'-Processing) inhibitor | 0.121 0.019 DBMET00574 | DBMET00574 | |
| 0.025 | 0.189 | 0.364 | Heparanase inhibitor | 0.06 0.023 DBMET00558 0.364 0.001 DBMET00593 0.19 0.002 DBMET00571 0.108 0.004 DBMET00574 0.076 0.008 DBMET02832 0.076 0.008 DBMET02833 0.076 0.008 DBMET02834 | DBMET00593 | |
| 0.12 | 0.288 | 0.769 | Angiogenesis inhibitor | 0.222 0.146 DB00624 0.212 0.156 DBMET00558 0.314 0.086 DBMET00593 0.276 0.106 DBMET00571 0.769 0.005 DBMET00574 0.218 0.15 DBMET02832 0.218 0.15 DBMET02833 0.218 0.15 DBMET02834 | DBMET00574 | |
| 0.018 | 0.187 | 0.085 | Antibiotic Aminoglycoside-like | 0.085 0.004 DBMET00593 0.08 0.004 DBMET00571 | DBMET00593 | |
| 0.039 | 0.212 | 0.137 | GABA A receptor agonist | 0.116 0.026 DBMET00558 0.137 0.018 DBMET02832 0.137 0.018 DBMET02833 0.137 0.018 DBMET02834 | DBMET02834 | |
| 0.017 | 0.194 | 0.063 | Argininosuccinate synthase inhibitor | 0.063 0.034 DBMET00558 | DBMET00558 | |
| 0.039 | 0.224 | 0.102 | ATPase (Vacuolar H+) inhibitor | 0.102 0.037 DBMET00593 0.098 0.042 DBMET00571 | DBMET00593 | |
| 0.057 | 0.244 | 0.12 | Glutamate release inhibitor | 0.097 0.047 DB00624 0.085 0.074 DBMET00558 0.12 0.022 DBMET00593 0.107 0.033 DBMET00571 0.097 0.048 DBMET02832 0.097 0.048 DBMET02833 0.097 0.048 DBMET02834 | DBMET00593 | |
| 0.117 | 0.306 | 0.361 | Transcription factor STAT inhibitor | 0.295 0.059 DB00624 0.296 0.058 DBMET00558 0.225 0.107 DBMET00593 0.361 0.03 DBMET02832 0.361 0.03 DBMET02833 0.361 0.03 DBMET02834 | DBMET02834 | |
| 0.096 | 0.287 | 0.323 | Cyclic AMP phosphodiesterase inhibitor | 0.156 0.142 DB00624 0.323 0.033 DBMET00593 0.227 0.076 DBMET00571 0.203 0.091 DBMET02832 0.203 0.091 DBMET02833 0.203 0.091 DBMET02834 | DBMET00593 | |
| 0.133 | 0.326 | 0.471 | Histamine release inhibitor | 0.46 0.045 DBMET00593 0.471 0.04 DBMET00571 | DBMET00571 | |
| 0.021 | 0.223 | 0.068 | Glucose-6-phosphate isomerase inhibitor | 0.051 0.028 DBMET00558 0.068 0.013 DBMET00593 0.059 0.02 DBMET00571 0.058 0.02 DBMET02832 0.058 0.02 DBMET02833 0.058 0.02 DBMET02834 | DBMET00593 | |
| 0.02 | 0.226 | 0.074 | GABA B receptor antagonist | 0.074 0.007 DBMET02832 0.074 0.007 DBMET02833 0.074 0.007 DBMET02834 | DBMET02834 | |
| 0.021 | 0.231 | 0.069 | Neuraminidase (influenza) inhibitor | 0.069 0.036 DBMET00593 0.062 0.049 DBMET00571 0.068 0.038 DBMET00574 | DBMET00593 | |
| 0.022 | 0.232 | 0.055 | Sphingosine kinase inhibitor | 0.055 0.049 DBMET02832 0.055 0.049 DBMET02833 0.055 0.049 DBMET02834 | DBMET02834 | |
| 0.025 | 0.236 | 0.182 | Topoisomerase II alpha inhibitor | 0.132 0.027 DBMET00593 0.182 0.018 DBMET00571 | DBMET00571 | |
| 0.086 | 0.306 | 0.318 | ATPase inhibitor | 0.168 0.074 DBMET00558 0.318 0.005 DBMET00593 0.278 0.009 DBMET00571 0.205 0.033 DBMET02832 0.205 0.033 DBMET02833 0.205 0.033 DBMET02834 | DBMET00593 | |
| 0.037 | 0.262 | 0.1 | GABA C receptor agonist | 0.1 0.066 DBMET02832 0.1 0.066 DBMET02833 0.1 0.066 DBMET02834 | DBMET02834 | |
| 0.031 | 0.257 | 0.077 | Adenine nucleotide translocase inhibitor | 0.057 0.035 DBMET00593 0.054 0.044 DBMET00571 0.077 0.011 DBMET00574 | DBMET00574 | |
| 0.04 | 0.27 | 0.115 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.083 0.076 DBMET00558 0.115 0.042 DBMET00593 0.089 0.066 DBMET00571 0.102 0.052 DBMET02832 0.102 0.052 DBMET02833 0.102 0.052 DBMET02834 | DBMET00593 | |
| 0.036 | 0.269 | 0.216 | UDP-glucose 4-epimerase inhibitor | 0.11 0.051 DB00624 0.128 0.038 DBMET00558 0.176 0.022 DBMET00593 0.216 0.016 DBMET00571 0.104 0.057 DBMET02832 0.104 0.057 DBMET02833 0.104 0.057 DBMET02834 | DBMET00571 | |
| 0.012 | 0.247 | 0.06 | Ceramide glucosyltransferase inhibitor | 0.04 0.017 DB00624 0.042 0.015 DBMET00558 0.049 0.008 DBMET00593 0.06 0.004 DBMET02832 0.06 0.004 DBMET02833 0.06 0.004 DBMET02834 | DBMET02834 | |
| 0.015 | 0.261 | 0.356 | Selectin antagonist | 0.356 0.004 DBMET00593 0.327 0.004 DBMET00571 0.281 0.006 DBMET00574 | DBMET00593 | |
| 0.005 | 0.252 | 0.089 | Carbonic anhydrase II inhibitor | 0.067 0.031 DBMET00558 0.061 0.034 DBMET00593 0.056 0.038 DBMET00571 0.089 0.022 DBMET00574 0.07 0.03 DBMET02832 0.07 0.03 DBMET02833 0.07 0.03 DBMET02834 | DBMET00574 | |
| 0.006 | 0.259 | 0.026 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET00593 0.026 0.005 DBMET00571 | DBMET00571 | |
| 0.013 | 0.266 | 0.176 | Phosphofructokinase-1 inhibitor | 0.075 0.044 DBMET00558 0.176 0.014 DBMET00593 0.152 0.018 DBMET00571 0.087 0.037 DBMET02832 0.087 0.037 DBMET02833 0.087 0.037 DBMET02834 | DBMET00593 | |
| 0.11 | 0.364 | 0.41 | Peptidyltransferase inhibitor | 0.168 0.151 DBMET00558 0.41 0.006 DBMET00593 0.397 0.007 DBMET00571 0.216 0.08 DBMET02832 0.216 0.08 DBMET02833 0.216 0.08 DBMET02834 | DBMET00593 | |
| 0.006 | 0.262 | 0.168 | Carbonic anhydrase inhibitor | 0.064 0.043 DBMET00558 0.067 0.041 DBMET00593 0.059 0.047 DBMET00571 0.168 0.013 DBMET00574 0.069 0.041 DBMET02832 0.069 0.041 DBMET02833 0.069 0.041 DBMET02834 | DBMET00574 | |
| 0.008 | 0.266 | 0.175 | NMDA 2D receptor antagonist | 0.175 0.003 DBMET00574 | DBMET00574 | |
| 0.012 | 0.272 | 0.143 | Alcohol oxidase inhibitor | 0.069 0.03 DB00624 0.143 0.011 DBMET00558 0.092 0.02 DBMET02832 0.092 0.02 DBMET02833 0.092 0.02 DBMET02834 | DBMET00558 | |
| 0.014 | 0.273 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.034 DBMET00593 | DBMET00593 | |
| 0.004 | 0.265 | 0.087 | Carbonic anhydrase IV inhibitor | 0.087 0.009 DBMET00558 0.038 0.035 DBMET00574 0.087 0.009 DBMET02832 0.087 0.009 DBMET02833 0.087 0.009 DBMET02834 | DBMET02834 | |
| 0.071 | 0.332 | 0.156 | CF transmembrane conductance regulator agonist | 0.134 0.109 DB00624 0.149 0.078 DBMET00558 0.156 0.066 DBMET02832 0.156 0.066 DBMET02833 0.156 0.066 DBMET02834 | DBMET02834 | |
| 0.007 | 0.27 | 0.11 | Phosphorylase inhibitor | 0.05 0.03 DBMET00558 0.11 0.012 DBMET00593 0.071 0.02 DBMET00571 0.079 0.017 DBMET02832 0.079 0.017 DBMET02833 0.079 0.017 DBMET02834 | DBMET00593 | |
| 0.035 | 0.307 | 0.18 | GABA receptor agonist | 0.148 0.037 DBMET00558 0.18 0.023 DBMET02832 0.18 0.023 DBMET02833 0.18 0.023 DBMET02834 | DBMET02834 | |
| 0.018 | 0.29 | 0.108 | NMDA receptor antagonist | 0.108 0.042 DBMET00574 | DBMET00574 | |
| 0.093 | 0.367 | 0.163 | CC chemokine 6 receptor antagonist | 0.128 0.078 DBMET00558 0.163 0.011 DBMET00593 0.156 0.015 DBMET00571 0.123 0.101 DBMET02832 0.123 0.101 DBMET02833 0.123 0.101 DBMET02834 | DBMET00593 | |
| 0.039 | 0.317 | 0.147 | Beta amyloid protein antagonist | 0.147 0.042 DBMET00593 0.098 0.093 DBMET02832 0.098 0.093 DBMET02833 0.098 0.093 DBMET02834 | DBMET00593 | |
| 0.013 | 0.294 | 0.456 | Cholecystokinin B agonist | 0.456 0.002 DBMET00574 | DBMET00574 | |
| 0.011 | 0.3 | 0.054 | Neuraminidase inhibitor | 0.054 0.051 DBMET00593 | DBMET00593 | |
| 0.013 | 0.313 | 0.108 | Alpha-mannosidase inhibitor | 0.057 0.031 DBMET00558 0.108 0.005 DBMET00593 0.085 0.009 DBMET00571 0.061 0.025 DBMET00574 0.071 0.016 DBMET02832 0.071 0.016 DBMET02833 0.071 0.016 DBMET02834 | DBMET00593 | |
| 0.027 | 0.328 | 0.204 | Topoisomerase II inhibitor | 0.181 0.038 DBMET00593 0.204 0.032 DBMET00571 | DBMET00571 | |
| 0.036 | 0.356 | 0.208 | EphB2 antagonist | 0.208 0.082 DBMET02832 0.208 0.082 DBMET02833 0.208 0.082 DBMET02834 | DBMET02834 | |
| 0.011 | 0.333 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.014 DBMET02832 0.028 0.014 DBMET02833 0.028 0.014 DBMET02834 | DBMET02834 | |
| 0.024 | 0.367 | 0.106 | Creatine kinase inhibitor | 0.106 0.053 DB00624 | DB00624 | |
| 0.031 | 0.381 | 0.306 | Alpha-N-acetylglucosaminidase inhibitor | 0.14 0.061 DB00624 0.184 0.039 DBMET00558 0.306 0.015 DBMET00593 0.211 0.031 DBMET00571 0.254 0.022 DBMET02832 0.254 0.022 DBMET02833 0.254 0.022 DBMET02834 | DBMET00593 | |
| 0.028 | 0.38 | 0.167 | Beta glucuronidase inhibitor | 0.101 0.067 DB00624 0.091 0.086 DBMET00558 0.167 0.019 DBMET00593 0.152 0.024 DBMET00571 | DBMET00593 | |
| 0.03 | 0.384 | 0.131 | Triose-phosphate isomerase inhibitor | 0.084 0.069 DBMET00558 0.124 0.03 DBMET00593 0.117 0.034 DBMET00571 0.131 0.027 DBMET00574 0.085 0.068 DBMET02832 0.085 0.068 DBMET02833 0.085 0.068 DBMET02834 | DBMET00574 | |
| 0.013 | 0.372 | 0.039 | Thymidine kinase inhibitor | 0.039 0.031 DBMET02832 0.039 0.031 DBMET02833 0.039 0.031 DBMET02834 | DBMET02834 | |
| 0.005 | 0.372 | 0.043 | Guanylate cyclase inhibitor | 0.043 0.028 DBMET00593 0.039 0.035 DBMET02832 0.039 0.035 DBMET02833 0.039 0.035 DBMET02834 | DBMET00593 | |
| 0.008 | 0.381 | 0.093 | Mannosidase inhibitor | 0.093 0.006 DBMET00593 0.071 0.011 DBMET00571 0.043 0.035 DBMET00574 0.052 0.023 DBMET02832 0.052 0.023 DBMET02833 0.052 0.023 DBMET02834 | DBMET00593 | |
| 0.01 | 0.383 | 0.07 | Carbamoyl phosphate synthetase inhibitor | 0.054 0.05 DBMET00558 0.07 0.035 DBMET02832 0.07 0.035 DBMET02833 0.07 0.035 DBMET02834 | DBMET02834 | |
| 0.008 | 0.385 | 0.055 | Acyl-CoA dehydrogenase inhibitor | 0.055 0.037 DBMET02832 0.055 0.037 DBMET02833 0.055 0.037 DBMET02834 | DBMET02834 | |
| 0.004 | 0.382 | 0.163 | NMDA 2 receptor antagonist | 0.163 0.014 DBMET00574 0.068 0.053 DBMET02832 0.068 0.053 DBMET02833 0.068 0.053 DBMET02834 | DBMET00574 | |
| 0.004 | 0.387 | 0.046 | Geranyltranstransferase inhibitor | 0.046 0.027 DBMET02832 0.046 0.027 DBMET02833 0.046 0.027 DBMET02834 | DBMET02834 | |
| 0.004 | 0.398 | 0.041 | Sodium/glucose cotransporter 2 inhibitor | 0.041 0.008 DBMET00593 0.031 0.012 DBMET00571 | DBMET00593 | |
| 0.04 | 0.447 | 0.11 | Adenylate kinase inhibitor | 0.099 0.069 DBMET00558 0.11 0.053 DBMET02832 0.11 0.053 DBMET02833 0.11 0.053 DBMET02834 | DBMET02834 | |
| 0.005 | 0.417 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.017 DBMET02832 0.03 0.017 DBMET02833 0.03 0.017 DBMET02834 | DBMET02834 | |
| 0.004 | 0.423 | 0.034 | Sodium/glucose cotransporter inhibitor | 0.034 0.009 DBMET00593 0.027 0.014 DBMET00571 | DBMET00593 | |
| 0.011 | 0.431 | 0.054 | Sphingosine kinase 2 inhibitor | 0.054 0.04 DBMET02832 0.054 0.04 DBMET02833 0.054 0.04 DBMET02834 | DBMET02834 | |
| 0.014 | 0.445 | 0.141 | Phospholipase D inhibitor | 0.095 0.018 DBMET00558 0.079 0.035 DBMET00593 0.096 0.017 DBMET00574 0.141 0.004 DBMET02832 0.141 0.004 DBMET02833 0.141 0.004 DBMET02834 | DBMET02834 | |
| 0.031 | 0.476 | 0.212 | Cyclin-dependent kinase 8 inhibitor | 0.147 0.082 DB00624 0.121 0.116 DBMET00558 0.212 0.028 DBMET02832 0.212 0.028 DBMET02833 0.212 0.028 DBMET02834 | DBMET02834 | |
| 0.027 | 0.475 | 0.126 | NADH dehydrogenase inhibitor | 0.08 0.076 DBMET00558 0.126 0.026 DBMET00593 0.112 0.033 DBMET00571 0.089 0.058 DBMET02832 0.089 0.058 DBMET02833 0.089 0.058 DBMET02834 | DBMET00593 | |
| 0.039 | 0.494 | 0.116 | Interleukin 12 antagonist | 0.116 0.033 DBMET00571 | DBMET00571 | |
| 0.003 | 0.459 | 0.068 | Carbonic anhydrase I inhibitor | 0.068 0.03 DBMET00574 | DBMET00574 | |
| 0.006 | 0.47 | 0.481 | NMDA 2B receptor antagonist | 0.481 0.003 DBMET00574 0.065 0.028 DBMET02832 0.065 0.028 DBMET02833 0.065 0.028 DBMET02834 | DBMET00574 | |
| 0.024 | 0.492 | 0.339 | Anticoagulant | 0.162 0.071 DBMET00593 0.126 0.104 DBMET00571 0.339 0.023 DBMET00574 | DBMET00574 | |
| 0.02 | 0.495 | 0.094 | GABA B receptor agonist | 0.094 0.021 DBMET02832 0.094 0.021 DBMET02833 0.094 0.021 DBMET02834 | DBMET02834 | |
| 0.003 | 0.5 | 0.048 | Cholecystokinin B antagonist | 0.048 0.011 DBMET00574 | DBMET00574 | |
| 0.014 | 0.515 | 0.102 | M18 aspartyl aminopeptidase inhibitor | 0.102 0.09 DB00624 | DB00624 | |
| 0.044 | 0.561 | 0.185 | Superoxide dismutase inhibitor | 0.185 0.135 DBMET00574 | DBMET00574 | |
| 0.003 | 0.57 | 0.016 | Sodium/hydrogen exchanger inhibitor | 0.016 0.015 DBMET02832 0.016 0.015 DBMET02833 0.016 0.015 DBMET02834 | DBMET02834 | |
| 0.014 | 0.59 | 0.089 | Uric acid excretion stimulant | 0.089 0.066 DBMET00593 | DBMET00593 | |
| 0.004 | 0.603 | 0.063 | Cholecystokinin antagonist | 0.063 0.017 DBMET00574 | DBMET00574 | |
| 0.003 | 0.625 | 0.224 | Cholecystokinin agonist | 0.224 0.003 DBMET00574 | DBMET00574 | |
| 0.015 | 0.637 | 0.218 | Alpha-glucosidase inhibitor | 0.218 0.207 DBMET00571 | DBMET00571 | |
| 0.027 | 0.664 | 0.145 | Hexokinase inhibitor | 0.131 0.103 DBMET00593 0.145 0.085 DBMET00571 | DBMET00571 | |
| 0.016 | 0.682 | 0.227 | Cell wall synthesis inhibitor | 0.227 0.021 DBMET00593 0.184 0.037 DBMET00571 0.15 0.065 DBMET00574 | DBMET00593 | |
| 0.003 | 0.705 | 0.092 | Cholecystokinin A antagonist | 0.092 0.01 DBMET00574 | DBMET00574 | |
| 0.009 | 0.765 | 0.065 | Histone deacetylase stimulant | 0.065 0.061 DBMET00593 | DBMET00593 | |
| 0.009 | 0.765 | 0.065 | Histone deacetylase SIRT1 stimulant | 0.065 0.061 DBMET00593 | DBMET00593 | |
| 0.003 | 0.783 | 0.023 | Motilin receptor agonist | 0.023 0.015 DBMET00593 | DBMET00593 | |
| 0.009 | 0.814 | 0.184 | Dual specificity phosphatase inhibitor | 0.184 0.064 DBMET00574 | DBMET00574 | |
| 0.002 | 0.822 | 0.161 | Cholecystokinin A agonist | 0.161 0.003 DBMET00574 | DBMET00574 | |
| 0.005 | 0.862 | 0.189 | Dual specificity phosphatase 3 inhibitor | 0.189 0.067 DBMET00574 | DBMET00574 | |
| 0.006 | 0.864 | 0.031 | Purinergic P2Y2 antagonist | 0.031 0.028 DBMET00574 | DBMET00574 | |
| 0.008 | 0.951 | 0.106 | Factor IXa inhibitor | 0.052 0.034 DBMET00593 0.106 0.009 DBMET00574 | DBMET00574 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |